Haemonetics Corp. (HAE) reported first quarter EPS of $0.59 Friday morning, which beat the consensus estimate of $0.54. The company now expects to report full year EPS of $2.33 to $2.43, compared to the consensus estimate of $2.36.
Haemonetics gapped up Friday and rose sharply in early trade, to close higher by $3.07 at $61.13 on above average volume. The stock has been climbing for the last 3 weeks and closed at a 7-month high.
For comments and feedback: editorial@rttnews.com